Chronic News and Research

RSS

Alcohol abuse spills over into critical care resources

A quarter of patients admitted to intensive care units in Scotland have alcohol problems, while a fifth have chronic alcohol disease, a survey finds.

20 Jul 2012

Low serum albumin associated with higher risk of graft failure in pediatric kidney transplants

For children receiving kidney transplants, a potentially correctable blood condition present in about one in four recipients is associated with a moderately increased risk of the graft's later failure, suggesting that clinicians should weigh whether transplant is advisable when the condition is present, according to UC Davis research presented today at the 24th International Congress of the Transplantation Society in Berlin.

20 Jul 2012

Study on relationship between pain and higher brain functions

University of Texas Medical Branch at Galveston professor Volker Neugebauer has been awarded a four-year, $1.36 million grant by the National Institute of Neurological Disorders and Stroke to conduct an innovative study of the relationship between pain and parts of the brain associated with cognitive thought and emotional response.

20 Jul 2012

Silymarin does not offer significant improvements for patients with HCV

Silymarin, an extract of milk thistle commonly used to treat chronic liver disease by millions of people around the World, does not offer significant improvements for patients, according to a new study conducted by a nationwide group of researchers including faculty at the Perelman School of Medicine at the University of Pennsylvania.

20 Jul 2012

Short-term infection with intestinal worms may provide long-term protection against TID

Short-term infection with intestinal worms may provide long-term protection against type I diabetes (TID), suggests a study conducted by William Gause, PhD, and colleagues at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School.

20 Jul 2012

SGC, Life Technologies to generate first-ever master set of epigenetic recombinant antibodies

Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.

20 Jul 2012

New blood sugar monitor: An interview with Sherita Hill Golden

Type 1 diabetes is a disorder in which the body makes proteins (antibodies) against the cells in the pancreas that produce insulin, destroying those cells. As a result, individuals are unable to secrete insulin to normalize blood sugar and hyperglycemia results.

20 Jul 2012

Study demonstrates how nerve stimulation paired with specific experiences can reorganize the brain

UT Dallas researchers recently demonstrated how nerve stimulation paired with specific experiences, such as movements or sounds, can reorganize the brain. This technology could lead to new treatments for stroke, tinnitus, autism and other disorders.

20 Jul 2012

Link between objectively measured sleep and subsequent institutionalization among older women

Tired? Scientists have discovered another possible benefit of a night of restful and uninterrupted sleep. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health fragmented or interrupted sleep could predict future placement in a nursing home or assisted living facility.

20 Jul 2012

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.

20 Jul 2012

Teva contributes $2.5M to The Franklin Institute for development of neuroscience exhibit

The Franklin Institute has received a $2.5 million contribution from leading global pharmaceutical company Teva Pharmaceuticals to develop a signature innovative exhibit at the museum exploring neuroscience and the human brain, entitled Your Brain. This contribution brings The Franklin Institute's Inspire Science fundraising campaign total to $65 million.

20 Jul 2012

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor.

20 Jul 2012

Cubist second quarter total net revenues increase 30% to $230.6M

Cubist Pharmaceuticals, Inc. today announced results for the second quarter ended June 30, 2012.

20 Jul 2012

Overweight, obesity prevalent in psychiatric inpatients

Most inpatients with psychiatric disorders are overweight or obese, say Australian researchers who urge closer monitoring of the physical health of patients with mental illnesses.

19 Jul 2012

HAS-BLED: Atrial fibrillation patients undergoing angioplasty can still take anticoagulants

Researchers say that oral anticoagulation could improve the prognosis of atrial fibrillation patients who undergo percutaneous coronary intervention, even if they have a high bleeding risk according to the HAS-BLED score.

19 Jul 2012

Researchers discover potential drug targets that might reduce ventilator-induced lung inflammation

When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immune response that can lead to excessive inflammation, new research suggests.

19 Jul 2012

Additional research required to assess effectiveness of herbal remedies for insomnia

Approximately 1 in 3 Americans suffers from chronic sleep deprivation and another 10-15% of the population has chronic insomnia. Sleep disorders can profoundly affect a person's whole life and have been linked to a range of diseases, including obesity, depression, anxiety, and inflammatory disorders.

19 Jul 2012

A quarter of patients admitted to Scottish ICUs have alcohol problems

A quarter of patients admitted to Scottish intensive care units have alcohol problems and the majority of those have chronic alcohol disease, with particular problems among men and younger people.

19 Jul 2012

ScinoPharm to offer commercial manufacturing of topiramate API for VIVUS' Qsymia

ScinoPharm announced today that its Tainan, Taiwan Facility will provide commercial manufacturing of topiramate active pharmaceutical ingredient ("API") for VIVUS' Qsymia, a new drug for the treatment of obesity approved by the United States Food and Drug Administration on July 17, 2012.

19 Jul 2012

Only 63% of New Yorkers on Medicaid with chronic conditions are adherent to drug regimens

A new study published online this month in the Journal of Urban Health conducted by researchers in the Department of Population Health at NYU Langone Medical Center, the New York City Department of Health and Mental Hygiene, and the New York State Department of Health found only 63 percent of New Yorkers on Medicaid with chronic conditions including hypertension, diabetes and high cholesterol are adherent to medication regimens.

19 Jul 2012

Chronic News and Research

Alcohol abuse spills over into critical care resources

Low serum albumin associated with higher risk of graft failure in pediatric kidney transplants

Study on relationship between pain and higher brain functions

Silymarin does not offer significant improvements for patients with HCV

Short-term infection with intestinal worms may provide long-term protection against TID

SGC, Life Technologies to generate first-ever master set of epigenetic recombinant antibodies

New blood sugar monitor: An interview with Sherita Hill Golden

Study demonstrates how nerve stimulation paired with specific experiences can reorganize the brain

Link between objectively measured sleep and subsequent institutionalization among older women

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

Teva contributes $2.5M to The Franklin Institute for development of neuroscience exhibit

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Cubist second quarter total net revenues increase 30% to $230.6M

Overweight, obesity prevalent in psychiatric inpatients

HAS-BLED: Atrial fibrillation patients undergoing angioplasty can still take anticoagulants

Researchers discover potential drug targets that might reduce ventilator-induced lung inflammation

Additional research required to assess effectiveness of herbal remedies for insomnia

A quarter of patients admitted to Scottish ICUs have alcohol problems

ScinoPharm to offer commercial manufacturing of topiramate API for VIVUS' Qsymia

Only 63% of New Yorkers on Medicaid with chronic conditions are adherent to drug regimens

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News